{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:14:31Z","timestamp":1791688471689,"version":"4.3.4"},"reference-count":165,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T00:00:00Z","timestamp":1380153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jhep.2013.09.020","type":"journal-article","created":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T09:37:59Z","timestamp":1380447479000},"page":"210-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":226,"title":["Autoimmune liver disease, autoimmunity and liver transplantation"],"prefix":"10.1016","volume":"60","author":[{"given":"Marco","family":"Carbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Neuberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.09.020_b0005","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.09.020_b0010","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2013.09.020_b0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2013.09.020_b0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2012.08.010","article-title":"Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population","volume":"91","author":"Nakamura","year":"2012","journal-title":"Am J Hum Gen"},{"key":"10.1016\/j.jhep.2013.09.020_b0025","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1093\/hmg\/dds359","article-title":"Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants","volume":"21","author":"Juran","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2013.09.020_b0030","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ng.2395","article-title":"Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis","volume":"44","author":"Liu","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2013.09.020_b0035","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.09.020_b0040","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2013.09.020_b0045","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis. American Association for the Study of Liver Diseases","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0055","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.09.020_b0060","first-page":"CD004385","article-title":"Methotrexate for primary biliary cirrhosis","volume":"20","author":"Gong","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhep.2013.09.020_b0065","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.20897","article-title":"Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis","volume":"42","author":"Combes","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2011.05.010","article-title":"Colchicine or methotrexate, with ursodiol, are effective after 20 years in a subset of patients with primary biliary cirrhosis","volume":"9","author":"Leung","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1572-0241.2003.07182.x","article-title":"Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate","volume":"98","author":"Lee","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.09.020_b0080","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.26018","article-title":"Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid","volume":"57","author":"Honda","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0085","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1111\/j.1572-0241.2002.05944.x","article-title":"Fenofibrate treatment in patients with primary biliary cirrhosis","volume":"97","author":"Ohira","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.09.020_b0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1872-034X.2007.00305.x","article-title":"The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: a prospective, multicenter study","volume":"38","author":"Iwasaki","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2013.09.020_b0095","unstructured":"<http:\/\/ir.interceptpharma.com\/>."},{"key":"10.1016\/j.jhep.2013.09.020_b0100","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/00365521.2012.682090","article-title":"Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis","volume":"47","author":"Srivastava","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.09.020_b0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1233533","article-title":"Autoantibodies and their antigens in autoimmune hepatitis","volume":"29","author":"Bogdanos","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2013.09.020_b0115","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/qjmed\/hch078","article-title":"Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study","volume":"97","author":"Watt","year":"2004","journal-title":"QJM"},{"key":"10.1016\/j.jhep.2013.09.020_b0130","first-page":"609","article-title":"Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis","volume":"10","author":"Feizi","year":"1972","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2013.09.020_b0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0140","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0168-8278(97)80417-5","article-title":"Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis","volume":"26","author":"Broome","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2013.09.020_b0150","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.dld.2011.05.009","article-title":"Immune-mediated diseases in primary sclerosing cholangitis","volume":"43","author":"Lamberts","year":"2011","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.jhep.2013.09.020_b0155","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2000.03292.x","article-title":"Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis","volume":"95","author":"Saarinen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.09.020_b0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2013.09.020_b0165","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/hep.24307","article-title":"Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9","volume":"53","author":"Janse","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0170","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0175","article-title":"Genome-wide association analysis in sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4","author":"Ellinghaus","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0180","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jhep.2009.11.029","article-title":"Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C","volume":"52","author":"Hov","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0185","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/gim.2012.157","article-title":"Implementing genomic medicine in the clinic: the future is here","volume":"15","author":"Manolio","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.jhep.2013.09.020_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-1536-5-1","article-title":"Genomics and proteomics in liver fibrosis and cirrhosis","volume":"5","author":"Hannivoort","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.jhep.2013.09.020_b0195","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.autrev.2012.12.005","article-title":"Infectome: a platform to trace infectious triggers of autoimmunity","volume":"12","author":"Bogdanos","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jhep.2013.09.020_b0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/jes.2010.50","article-title":"Implications of the exposome for exposure science","volume":"21","author":"Rappaport","year":"2011","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"10.1016\/j.jhep.2013.09.020_b0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cbi.2011.02.010","article-title":"Benzene, the exposome and future investigations of leukemia etiology","volume":"192","author":"Smith","year":"2011","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jhep.2013.09.020_b0210","doi-asserted-by":"crossref","first-page":"e10746","DOI":"10.1371\/journal.pone.0010746","article-title":"An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus","volume":"5","author":"Patel","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.09.020_b0215","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/gut.2009.184218","article-title":"Case\u2013control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations","volume":"59","author":"Prince","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2013.09.020_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.01.010","article-title":"The critical importance of epigenetics in autoimmunity","volume":"41","author":"Lu","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2013.09.020_b0225","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0230","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2013.09.020_b0235","unstructured":"Nordic Liver Transplant Registry. Available at: <www.scandiatransplant.org>."},{"key":"10.1016\/j.jhep.2013.09.020_b0240","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep.510290229","article-title":"Quality of life before and after liver transplantation for cholestatic liver disease","volume":"29","author":"Gross","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jhep.2013.02.019","article-title":"The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort","volume":"59","author":"Pells","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2013.04.017","article-title":"The Effect of Liver Transplantation on Fatigue in Patients with Primary Biliary Cirrhosis \u2013 A Prospective Study","author":"Carbone","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0255","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0260","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.21964","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms","volume":"47","author":"Melum","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0265","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.09.020_b0270","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.09.020_b0275","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10620-010-1444-6","article-title":"Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series","volume":"56","author":"Wong","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2013.09.020_b0280","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/hep.26176","article-title":"Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan","volume":"57","author":"Harada","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0285","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/jhep.2002.33157","article-title":"Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis","volume":"35","author":"Shibuya","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MEG.0b013e3282f163ed","article-title":"Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis","volume":"20","author":"Deutsch","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0295","first-page":"279","article-title":"Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn\u2019s disease. A case report","volume":"53","author":"Demarchi","year":"2007","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.jhep.2013.09.020_b0300","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0168-8278(97)80356-X","article-title":"Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?","volume":"27","author":"Harnois","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0305","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1053\/j.gastro.2009.08.070","article-title":"Long-term probability of and mortality from de novo malignancy after liver transplantation","volume":"137","author":"Watt","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.09.020_b0310","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/lt.21916","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation","volume":"15","author":"Duclos-Vallee","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0315","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0320","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0325","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.09.020_b0330","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0030-1255557","article-title":"Endoscopic retrograde cholangiopancreatography using a single-balloon enteroscope in patients with altered Roux-en-Y anatomy","volume":"42","author":"Saleem","year":"2010","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2013.09.020_b0335","first-page":"275","article-title":"Double balloon enteroscopy for endoscopic retrograde cholangiopancreaticography after Roux-en-Y reconstruction: case series and review of the literature","volume":"66","author":"Koornstra","year":"2008","journal-title":"Neth J Med"},{"key":"10.1016\/j.jhep.2013.09.020_b0340","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2013.09.020_b0345","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2013.09.020_b0350","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1600-6143.2010.03080.x","article-title":"Phenotypic expression of recurrent disease after liver transplantation","volume":"10","author":"O\u2019Grady","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.09.020_b0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","article-title":"Aetiopathogenesis of autoimmune hepatitis","volume":"34","author":"Longhi","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2013.09.020_b0360","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0365","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0370","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hep.22435","article-title":"Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database","volume":"48","author":"Balan","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0375","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","author":"Montano-Loza","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0380","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0385","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/ajt.12132","article-title":"Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Carbone","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.09.020_b0390","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Morioka","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0395","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0400","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0405","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jlts.2003.36392","article-title":"Liver transplantation for primary biliary cirrhosis: a long-term pathologic study","volume":"9","author":"Khettry","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0410","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/lt.21960","article-title":"Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity","volume":"16","author":"Manousou","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0415","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0420","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.09.020_b0425","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0430","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0435","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0440","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1478-3231.2011.02459.x","article-title":"Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation","volume":"31","author":"Ten Hove","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.09.020_b0445","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1478-3231.2010.02422.x","article-title":"The combination of primary sclerosing cholangitis and CCR5-\u039432 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation","volume":"31","author":"op den Dries","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.09.020_b0450","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry","volume":"11","author":"Egawa","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.09.020_b0455","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0460","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/TP.0b013e3182845f6c","article-title":"Late acute liver allograft rejection; a study of its natural history and graft survival in the current era","volume":"95","author":"Thurairajah","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0465","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/hep.510230207","article-title":"Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins","volume":"23","author":"Farges","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0470","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis","volume":"18","author":"Vogel","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2013.09.020_b0475","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s004230050201","article-title":"Primary liver disease as a determinant for acute rejection after liver transplantation","volume":"384","author":"Seiler","year":"1999","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.jhep.2013.09.020_b0480","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.510280306","article-title":"Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome","volume":"28","author":"Wiesner","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0485","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jlts.2002.32981","article-title":"Incidence and recurrence of autoimmune\/alloimmune hepatitis in liver transplant recipients","volume":"8","author":"Molmenti","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0490","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200008150-00014","article-title":"Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors","volume":"70","author":"Milkiewicz","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0495","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00007890-199602270-00007","article-title":"The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation","volume":"61","author":"Berlakovich","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0500","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0012.2007.00788.x","article-title":"Late acute rejection after liver transplantation impacts patient survival","volume":"22","author":"Uemura","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2013.09.020_b0505","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/lt.500040313","article-title":"Allograft rejection after liver transplantation for autoimmune liver diseases","volume":"4","author":"Hayashi","year":"1998","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.jhep.2013.09.020_b0510","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0515","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.09.020_b0520","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.1840220213","article-title":"Liver transplantation for sclerosing cholangitis","volume":"22","author":"Narumi","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0525","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/bjs.1800820836","article-title":"Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation","volume":"82","author":"Miki","year":"1995","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2013.09.020_b0530","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0535","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.athoracsur.2008.03.073","article-title":"Immunological link between primary graft dysfunction and chronic lung allograft rejection","volume":"86","author":"Bharat","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jhep.2013.09.020_b0540","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1164\/rccm.200608-1079OC","article-title":"Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome","volume":"175","author":"Daud","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jhep.2013.09.020_b0545","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/eci.12.58","article-title":"Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens","volume":"8","author":"Subramanian","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jhep.2013.09.020_b0550","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1432-2277.2009.00884.x","article-title":"Role of NK and NKT cells in solid organ transplantation","volume":"22","author":"Pratschke","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2013.09.020_b0555","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1600-6143.2008.02341.x","article-title":"Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation","volume":"8","author":"Hanvesakul","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.09.020_b0560","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"MHC class I molecules and KIRs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2013.09.020_b0565","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jhep.2007.01.032","article-title":"Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis","volume":"46","author":"Karlsen","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0570","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0025-6196(12)60897-0","article-title":"Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis","volume":"68","author":"Hashimoto","year":"1993","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2013.09.020_b0575","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/gast.2002.36020","article-title":"Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer","volume":"123","author":"Kita","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.09.020_b0580","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.24113","article-title":"Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis","volume":"53","author":"Wu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0585","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.22052","article-title":"Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis","volume":"47","author":"Chuang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0590","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2249.2012.04581.x","article-title":"The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis","volume":"168","author":"Shimoda","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2013.09.020_b0595","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhep.2003.10.022","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"40","author":"Mieli-Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0600","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1399-0012.2007.00667.x","article-title":"Clinical relevance of autoantibodies after pediatric liver transplantation","volume":"21","author":"Richter","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2013.09.020_b0605","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.transproceed.2011.05.030","article-title":"De novo autoimmune hepatitis in Korean children after liver transplantation: a single institution\u2019s experience","volume":"43","author":"Cho","year":"2011","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhep.2013.09.020_b0610","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s10620-012-2179-3","article-title":"Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2013.09.020_b0615","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0620","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/lt.21721","article-title":"Risk factors for developing de novo autoimmune hepatitis associate with anti-glutathione S-transferase T1 antibodies after liver transplantation","volume":"15","author":"Salcedo","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0625","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.TP.0000132328.33460.43","article-title":"Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation","volume":"78","author":"Miyagawa-Hayashino","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0630","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1600-6143.2006.01717.x","article-title":"Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis","volume":"7","author":"Venick","year":"2007","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0635","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1016\/j.transproceed.2005.10.042","article-title":"Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation","volume":"37","author":"Aguilera","year":"2005","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhep.2013.09.020_b0640","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1399-0012.2007.00787.x","article-title":"De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis","volume":"22","author":"Yoshizawa","year":"2008","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0645","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-0012.2010.01221.x","article-title":"Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation","volume":"25","author":"Aguilera","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2013.09.020_b0650","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1432-2277.2010.01143.x","article-title":"Current views on rejection pathology in liver transplantation","volume":"23","author":"Neil","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2013.09.020_b0655","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/17474124.1.1.113","article-title":"Autoimmune hepatitis Part A: pathogenesis","volume":"1","author":"Czaja","year":"2007","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0660","doi-asserted-by":"crossref","first-page":"S462","DOI":"10.1111\/j.1872-034X.2007.00287.x","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"37","author":"Lohse","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2013.09.020_b0665","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1572-0241.2001.03707.x","article-title":"Understanding the pathogenesis of autoimmune hepatitis","volume":"96","author":"Czaja","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.09.020_b0670","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4049\/jimmunol.182.1.309","article-title":"Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection","volume":"182","author":"Fukami","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2013.09.020_b0675","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1600-6143.2011.03917.x","article-title":"An obligatory role for lung infiltrating B cells in the immunopathogenesis of obliterative airway disease induced by antibodies to MHC class I molecules","volume":"12","author":"Fukami","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.09.020_b0680","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/lt.21518","article-title":"Plasma cell hepatitis in liver allografts: variant of rejection or autoimmune hepatitis?","volume":"14","author":"Demetris","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0685","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhep.2010.11.012","article-title":"Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients","volume":"55","author":"Selzner","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0690","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.21280","article-title":"Liver biopsy interpretation for causes of late liver allograft dysfunction","volume":"44","author":"Banff Working Group","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0695","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00000478-199502000-00008","article-title":"Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation","volume":"19","author":"Pappo","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2013.09.020_b0700","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/00007890-199305000-00027","article-title":"Causes of late graft loss after liver transplantation","volume":"55","author":"B\u00e4ckman","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0705","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/lt.21404","article-title":"The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers","volume":"14","author":"Krasinskas","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0710","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00007890-199707270-00013","article-title":"Central venulitis in the allograft liver: a clinicopathologic study","volume":"64","author":"Tsamandas","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0715","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/jlts.2001.23085","article-title":"Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome","volume":"7","author":"Hubscher","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0720","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International panel","volume":"31","author":"Demetris","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0725","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.lts.2003.09.018","article-title":"Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry","volume":"9","author":"Adam","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0730","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0735","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease","volume":"30","author":"Ratziu","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0740","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0745","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","author":"Gonz\u00e1lez-Koch","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0750","first-page":"176A","article-title":"Transplantation for primary biliary cirrhosis: disease recurrence and outcome in 421 patients","volume":"26","author":"Abu-Elmagd","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0755","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0760","first-page":"35","article-title":"Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation?","volume":"13","author":"Jacob","year":"2008","journal-title":"Ann Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0765","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience","volume":"225","author":"Goss","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2013.09.020_b0770","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0775","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.09.020_b0780","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2013.07.004","article-title":"Novel insights into autoimmune liver diseases provided by genome-wide association studies","volume":"46","author":"Mells","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2013.09.020_b0785","first-page":"1563","article-title":"A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis","volume":"23","author":"McEntee","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2013.09.020_b0790","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00000658-199206000-00006","article-title":"The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation","volume":"215","author":"Shaked","year":"1992","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2013.09.020_b0795","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/00007890-200004150-00054","article-title":"The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection","volume":"69","author":"Bathgate","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0800","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.20444","article-title":"Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors","volume":"11","author":"Brandsaeter","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.09.020_b0805","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.09.020_b0810","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation","volume":"71","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.09.020_b0815","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1111\/j.1440-1746.2008.05347.x","article-title":"De novo autoimmune hepatitis after living donor liver transplantation is unlikely to be related to immunoglobulin subtype 4-related immune disease","volume":"23","author":"Eguchi","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.09.020_b0820","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.transproceed.2011.05.030","article-title":"De novo autoimmune hepatitis in Korean children after liver transplantation: a single institution\u2019s experience","volume":"43","author":"Cho","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2013.09.020_b0825","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00005176-200102000-00007","article-title":"Autoimmune hepatitis as a late complication of liver transplantation","volume":"32","author":"Hernandez","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813006806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813006806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T20:59:49Z","timestamp":1564174789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813006806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":165,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0168827813006806"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.09.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune liver disease, autoimmunity and liver transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2013.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}